Article Text

Download PDFPDF
Patient Characteristics and Participation in a Genetic Study
  1. Loabat Amiri, MD*,
  2. Andrea E. Cassidy-Bushrow, PhD, MPH,
  3. Heather Dakki, MPH,
  4. Jia Li, PhD,
  5. Karen Wells, MPH,
  6. Susan A. Oliveria, ScD,
  7. Marianne Ulcickas Yood, DSc,
  8. Abraham Thomas, MD, MPH*,
  9. David E. Lanfear, MD, MS, FACC§
  1. From the *Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System; and †Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI; ‡EpiSource, Newton, MA; and §Heart and Vascular Institute and Center for Health Services and Policy Research, Henry Ford Health System, Detroit, MI.
  1. Received May 4, 2013, and in revised form September 24, 2013.
  2. Accepted for publication September 26, 2013.
  3. This study was supported by funding from Sanofi-Aventis and by a contract from EpiSource, LLC.
  4. Reprints: David E. Lanfear, MD, MS, FACC, Henry Ford Hospital, 2799 W Grand Blvd, K14, Detroit, MI 48202. E-mail: dlanfea1{at}hfhs.org.

A Type 2 Diabetes Cohort

Abstract

Background Recruitment of large, diverse populations into genetic studies remains challenging. Potential strategies to overcome limitations include leveraging electronic health data and minimizing patient burden. We sought to describe the overall participation rate and identify characteristics associated with participation in a genetic substudy of patients with type 2 diabetes mellitus, in which patients were identified via electronic hospital data and asked to participate by providing DNA samples by mail.

Methods During a phone interview, participants (n = 455) were asked to take part in a genetic substudy. Subjects verbally consenting were mailed saliva collection kits and written consent forms. We examined demographic and clinical variables associated with verbal consent and DNA kit return using logistic regression.

Results Overall, 90% (n = 410) verbally consented to the genetic substudy during interviews. However, of those consenting, only 70% returned the DNA kit (n = 287). Among those consenting, after covariate adjustment, male sex (odds ratio [OR], 1.70; 95% confidence interval [CI], 1.09–2.65), African American race (OR, 0.61; 95% CI, 0.39–0.95), hemoglobin A1c (HbA1c) (OR, 0.87; 95% CI, 0.75–1.00), and physical activity (OR, 0.58; 95% CI, 0.37–0.91) were significantly associated with DNA kit return.

Conclusions To our knowledge, we are the first to demonstrate an inverse association between HbA1c and participation in genetic research, potentially indicating a compliance-related trait needing further exploration. The DNA kit return rate being notably lower than the verbal consent rate suggests that the greater convenience of a telephone/mail-in process did not drastically enhance full participation. Direct comparison to in-person donation may be warranted.

Key Words
  • genetics
  • type 2 diabetes
  • race
  • recruitment

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.